Key facts
- Vista.ai’s last known valuation is $476.0M (Jan 2026).
- It has raised $42.1M; the latest was Later Stage VC ($29.5M) in Jan 2026.
- Notable investors include Khosla Ventures, StartX (US), DNX Ventures, Open Field Capital, Leslie Ventures — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Vista.ai
- ·The full record, as it builds
Funding rounds
No funding rounds for Vista.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vista.ai
Developer of a diagnostic imaging technology designed to aid in cardiovascular diseases. The company's technology uses artificial intelligence to control the scanner leverages machine learning for fast and accurate scans and automatically prescribes the standard cardiac views, enabling healthcare providers to reduce discomfort and increase access for patients with health constraints.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2005
- Employees
- 30
- Website
- vista.ai/
- Ownership
- Privately Held (backing)
Vista.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vista.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vista.ai in its N-PORT filings yet. We sweep new filings monthly.